Clinical Trial Update: Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing corifollitropin alfa with daily recombinant FSH for controlled ovarian stimulation in poor responders was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Corifollitropin alfa (Corifollitropin alfa)
• recombinant FSH (follicle-stimulating hormone)

Snippet

Sponsor: Vida Recoletas Sevilla | Conditions: Infertility | Phase 4 | Status: TERMINATED